Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8233 ARTÍCULOS , VIENDO DEL 1051 AL 1065

Longitudinal Trajectories of the Cognitive Function Index in the A4 Study

Amariglio RE, Grill JD, Rentz DM, Marshall GA, Donohue MC, Liu A, Aisen PS, Sperling RA.

J Prev Alzheimers Dis. 2024;11(4):838-845. doi: 10.14283/jpad.2024.125.

Brexpiprazole for Agitation Associated With Dementia Due to Alzheimer's Disease

Lee D, Clark ED, Antonsdottir IM, Porsteinsson AP.

J Am Med Dir Assoc. 2024 Oct;25(10):105173. doi: 10.1016/j.jamda.2024.105173. Epub 2024 Jul 22.

A Protocol for the Inclusion of Minoritized Persons in Alzheimer Disease Research From the ADNI3 Diversity Taskforce

Okonkwo OC, Rivera Mindt M, Ashford MT, Conti C, Strong J, Raman R, Donohue MC, Nosheny RL, Flenniken D, Miller MJ, Diaz A, Soto AM, Ances BM, Beigi MR, Doraiswamy PM, Duara R, Farlow MR, Grossman HT, Mintzer JE, Reist C, Rogalski EJ, Sabbagh MN, Salloway S, Schneider LS, Shah RC, Petersen RC, Aisen PS, Weiner MW; Alzheimer’s Disease Neuroimaging Initiative.

JAMA Netw Open. 2024 Aug 1;7(8):e2427073. doi: 10.1001/jamanetworkopen.2024.27073.

Blood Pressure, Antihypertensive Use, and Late-Life Alzheimer and Non-Alzheimer Dementia Risk: An Individual Participant Data Meta-Analysis

Lennon MJ, Lipnicki DM, Lam BCP, Crawford JD, Schutte AE, Peters R, Rydberg-Sterner T, Najar J, Skoog I, Riedel-Heller SG, Röhr S, Pabst A, Lobo A, De-la-Cámara C, Lobo E, Lipton RB, Katz MJ, Derby CA, Kim KW, Han JW, Oh DJ, Rolandi E, Davin A, Rossi M, Scarmeas N, Yannakoulia M, Dardiotis T, Hendrie HC, Gao S, Carriere I, Ritchie K, Anstey KJ, Cherbuin N, Xiao S, Yue L, Li W, Guerchet M, Preux PM, Aboyans V, Haan MN, Aiello A, Scazufca M, Sachdev PS; as the Cohort Studies of Memory in an International Consortium (COSMIC) Group.

Neurology. 2024 Sep 10;103(5):e209715. doi: 10.1212/WNL.0000000000209715. Epub 2024 Aug 14.

Carotenoid Supplementation for Alleviating the Symptoms of Alzheimer's Disease

Flieger J, Forma A, Flieger W, Flieger M, Gawlik PJ, Dzierżyński E, Maciejewski R, Teresiński G, Baj J.

Int J Mol Sci. 2024 Aug 18;25(16):8982. doi: 10.3390/ijms25168982.

Recent advancement in understanding of Alzheimer's disease: Risk factors, subtypes, and drug targets and potential therapeutics

Prabha S, Sajad M, Hasan GM, Islam A, Imtaiyaz Hassan M, Thakur SC.

Ageing Res Rev. 2024 Nov;101:102476. doi: 10.1016/j.arr.2024.102476. Epub 2024 Aug 31.

Donanemab: First Approval

Kang C.

Drugs. 2024 Oct;84(10):1313-1318. doi: 10.1007/s40265-024-02087-4. Epub 2024 Sep 6.

Impact of Peptide Transport and Memory Function in the Brain

Cheng L, Shi C, Li X, Matsui T.

Nutrients. 2024 Sep 2;16(17):2947. doi: 10.3390/nu16172947.

Profiling aducanumab as a treatment option for Alzheimer's disease: an overview of efficacy, safety and tolerability

Thussu S, Naidu A, Manivannan S, Grossberg GT.

Expert Rev Neurother. 2024 Nov;24(11):1045-1053. doi: 10.1080/14737175.2024.2402058. Epub 2024 Sep 18.

Reversibility of cognitive worsening observed with BACE inhibitor umibecestat in the Alzheimer's Prevention Initiative (API) Generation Studies

Tariot PN, Riviere ME, Salloway S, Burns JM, Snaedal JG, Borowsky B, Lopez CL, Liu F, Rouzade-Dominguez ML, Cazorla P, Mousseau MC, Arkuszewski M, Ricart J, Viglietta V, Sui Y, Caputo A, Langbaum JB, Reiman EM, Graf A.

Alzheimers Dement. 2024 Nov;20(11):7745-7761. doi: 10.1002/alz.14237. Epub 2024 Sep 25.

Alzheimer's Disease Linkage to Real-World Evidence (AD-LINE) Study: Linking Claims Data to Phase 3 GRADUATE Study of Gantenerumab

Fillit H, Seleri Assunção S, Majda T, Ng CD, To TM, Abbass IM, Raimundo K, Wallick C, Tcheremissine OV.

J Prev Alzheimers Dis. 2024;11(5):1251-1259. doi: 10.14283/jpad.2024.115.

Davunetide sex-dependently boosts memory in prodromal Alzheimer's disease

Gozes I, Blatt J, Lobyntseva A.

Transl Psychiatry. 2024 Oct 2;14(1):412. doi: 10.1038/s41398-024-03118-0.

Brexpiprazole treatment for agitation in Alzheimer's dementia: A randomized study

Nakamura Y, Adachi J, Hirota N, Iba K, Shimizu K, Nakai M, Takahashi K, Mori N.

Alzheimers Dement. 2024 Nov;20(11):8002-8011. doi: 10.1002/alz.14282. Epub 2024 Oct 6.

Alzheimer's Disease: Exploring the Landscape of Cognitive Decline

Tenchov R, Sasso JM, Zhou QA.

ACS Chem Neurosci. 2024 Nov 6;15(21):3800-3827. doi: 10.1021/acschemneuro.4c00339. Epub 2024 Oct 11.

A Randomized-Controlled Trial Targeting Cognition in Early Alzheimer's Disease by Improving Sleep with Trazodone (REST)

Eyob E, Shaw JS, Bakker A, Munro C, Spira A, Wu M, Rabinowitz JA, Peters M, Wanigatunga S, Zipunnikov V, Thompson R, Burhanullah MH, Leoutsakos JM, Rosenberg P, Greenberg B.

J Alzheimers Dis. 2024;101(s1):S205-S215. doi: 10.3233/JAD-230635.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias